T Rowe Price Retirement 2065 Fund I Class News - TRMOX

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-179590 Prospectus Supplement...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")

Marshall Edwards Announces Name Change to MEI Pharma ("MEIP") New Name and Ticker Symbol Effective Monday, July 2, 2012 PR Newswire SAN DIEGO...

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-179590 Prospectus Supplement No. 4 (to Prospectus dated March 26...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...

Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143

Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143 Data Presented at the American Society of Clinical...

Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344

Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344 PR Newswire SAN DIEGO, May...

- Amended Statement of Beneficial Ownership (SC 13D/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Information To Be...

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

Table of Contents Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-179590 Prospectus Supplement No. 3 (to Prospectus dated...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ...

Marshall Edwards Completes Rights Offering To Stockholders

Marshall Edwards Completes Rights Offering To Stockholders PR Newswire SAN DIEGO, May 14, 2012 SAN DIEGO, May 14, 2012 /PRNewswire/ -- Marshall...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

T Rowe Price Retirement 2065 Fund I Class (TRMOX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

TRMOX News

- Statement of Changes in Beneficial Ownership (4)

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Current report filing (8-K)

Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Current report filing (8-K)

Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143

Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344

- Amended Statement of Beneficial Ownership (SC 13D/A)

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Quarterly Report (10-Q)

Marshall Edwards Completes Rights Offering To Stockholders

TRMOX Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

T Rowe Price Retirement 2065 Fund I Class (TRMOX) News

T Rowe Price Retirement 2065 Fund I Class (TRMOX)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

TRMOX News

- Statement of Changes in Beneficial Ownership (4)

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Current report filing (8-K)

Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Current report filing (8-K)

Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143

Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344

- Amended Statement of Beneficial Ownership (SC 13D/A)

- Prospectus filed pursuant to Rule 424(b)(3) (424B3)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Statement of Changes in Beneficial Ownership (4)

- Quarterly Report (10-Q)

Marshall Edwards Completes Rights Offering To Stockholders

TRMOX Discussion

Your Recent History